GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Maxigen Biotech 1783.TW · TWD

Consumer Staples · Taiwan Stock Exchange · 🇹🇼 Taiwan

Compare

35.25

+1.59%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 811.6m

FY2016FY2025

Net income

TWD 265.3m

FY2016FY2025

Free cash flow

TWD 207.6m

FY2016FY2025

Shareholders' equity

TWD 1.54bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueTWD 811.6mTWD 680.7mTWD 622.1mTWD 604.4mTWD 512.0mTWD 457.7mTWD 452.2mTWD 427.7mTWD 427.6mTWD 336.4m
Gross profitTWD 563.7mTWD 483.3mTWD 424.1mTWD 374.0mTWD 261.0mTWD 214.5mTWD 217.3mTWD 182.6mTWD 160.3mTWD 134.9m
Research and developmentTWD 126.1mTWD 111.8mTWD 68.6mTWD 99.6mTWD 75.7mTWD 69.2mTWD 66.9mTWD 50.7mTWD 43.3mTWD 36.3m
Operating incomeTWD 261.0mTWD 194.4mTWD 149.8mTWD 170.6mTWD 100.7mTWD 76.9mTWD 76.1mTWD 50.1mTWD 21.0m−TWD 7.1m
Net incomeTWD 265.3mTWD 190.2mTWD 165.8mTWD 139.4mTWD 87.7mTWD 63.3mTWD 60.1mTWD 57.1mTWD 15.8m−TWD 12.2m
Diluted earnings per share2.962.111.841.611.050.850.790.730.20-0.17

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTWD 1.89bnTWD 1.58bnTWD 1.49bnTWD 1.45bnTWD 1.27bnTWD 956.5mTWD 1.19bnTWD 1.14bnTWD 1.10bnTWD 1.10bn
Cash and short-term investmentsTWD 877.7mTWD 640.6mTWD 432.6mTWD 801.3mTWD 540.2mTWD 222.9mTWD 432.7mTWD 417.1mTWD 305.3mTWD 354.7m
Total liabilitiesTWD 355.5mTWD 207.4mTWD 131.9mTWD 152.1mTWD 123.5mTWD 96.2mTWD 334.2mTWD 292.5mTWD 307.7mTWD 316.0m
DebtTWD 101.4m———TWD 9.6mTWD 12.1mTWD 14.7m—TWD 226.3mTWD 226.2m
Shareholders' equityTWD 1.54bnTWD 1.38bnTWD 1.36bnTWD 1.30bnTWD 1.14bnTWD 860.2mTWD 851.3mTWD 843.0mTWD 796.3mTWD 781.4m
Shares outstanding90m90m90m87m84m75m77m78m77m73m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsTWD 290.2mTWD 298.2mTWD 171.2mTWD 268.3mTWD 117.6mTWD 74.4mTWD 94.4mTWD 170.6mTWD 41.2mTWD 34.7m
Capital spending−TWD 82.6m−TWD 31.8m−TWD 22.4m−TWD 14.4m−TWD 15.4m−TWD 11.3m−TWD 23.7m−TWD 20.2m−TWD 29.0m−TWD 72.7m
Free cash flowTWD 207.6mTWD 266.5mTWD 148.8mTWD 253.9mTWD 102.1mTWD 63.1mTWD 70.7mTWD 150.4mTWD 12.2m−TWD 38.0m
Dividends paid−TWD 74.4m−TWD 89.0m−TWD 42.4m—−TWD 56.3m−TWD 54.2m−TWD 51.9m−TWD 10.8m−TWD 10.8m−TWD 10.8m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueTWD 221.0mTWD 190.9mTWD 224.7mTWD 200.9mTWD 208.8mTWD 177.2mTWD 205.6mTWD 173.9m
Gross profitTWD 150.6mTWD 134.6mTWD 165.3mTWD 135.0mTWD 138.2mTWD 125.2mTWD 151.0mTWD 128.4m
Operating incomeTWD 56.8mTWD 58.4mTWD 86.5mTWD 53.1mTWD 69.1mTWD 39.1mTWD 69.9mTWD 49.9m
Net incomeTWD 79.1mTWD 52.8mTWD 83.7mTWD 75.5mTWD 58.9mTWD 47.1mTWD 52.5mTWD 49.5m
Diluted earnings per share1.470.980.940.840.660.530.580.55
Cash from operationsTWD 74.0mTWD 79.0mTWD 96.0mTWD 81.0mTWD 36.0mTWD 74.0mTWD 82.0mTWD 116.0m
Capital spending−TWD 17.0m−TWD 10.0m−TWD 42.0m−TWD 21.0m−TWD 9.0m−TWD 8.0m−TWD 13.0m−TWD 5.0m
Free cash flowTWD 57.0mTWD 69.0mTWD 54.0mTWD 60.0mTWD 27.0mTWD 66.0mTWD 69.0mTWD 111.0m
Total assetsTWD 2.03bnTWD 1.99bnTWD 1.89bnTWD 1.71bnTWD 1.69bnTWD 1.70bnTWD 1.58bnTWD 1.53bn
Cash and short-term investmentsTWD 997.3mTWD 951.0mTWD 877.7mTWD 732.6mTWD 739.3mTWD 704.4mTWD 640.6mTWD 545.3m
DebtTWD 102.3mTWD 100.5mTWD 101.4mTWD 1.4m———TWD 20,000
Shareholders' equityTWD 1.50bnTWD 1.63bnTWD 1.54bnTWD 1.47bnTWD 1.41bnTWD 1.48bnTWD 1.38bnTWD 1.33bn

Financial ratios

Data as of 20 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Gross margin69.5%71.0%68.2%61.9%51.0%46.9%——
Operating margin32.2%28.6%24.0%27.4%19.1%16.8%——
Net margin32.7%27.9%26.7%23.1%17.1%13.8%——
Return on equity17.3%13.8%12.2%10.8%7.7%7.4%——
Return on assets14.0%12.0%11.1%9.6%6.9%6.6%——
Free cash flow yield8.8%9.0%5.1%8.4%3.8%2.7%——
Revenue growth19.2%9.4%2.9%18.1%11.9%1.2%——
Earnings growth39.5%14.7%19.0%59.0%38.5%5.3%——
Current ratio3.21x4.03x4.72x6.56x6.75x4.99x——
Debt to equity0.07x—0.00x—0.00x-0.00x0.00x0.25x
Equity ratio81.2%86.9%91.2%89.5%90.2%89.9%——
Interest coverage6070.74x——2438.94x498.28x307.68x22.22x15.27x
R&D as a share of sales15.5%16.4%11.0%16.5%14.8%15.1%——
Buybacks as a share of market value0.4%0.3%-3.9%-3.7%-12.3%2.6%——

Growth per year

Compound annual rate

3 years5 years10 years
Revenue10.3%12.1%12.0%
Operating income15.2%27.7%—
Net income23.9%33.2%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin70.2%67.9%62.9%55.5%
Operating margin30.5%28.5%25.8%18.5%
Net margin30.5%28.0%24.7%17.3%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings14.423.126.328.342.923.427.927.395.5-122.7
Price to sales4.76.57.06.57.33.23.73.63.54.5

Dividends and splits

Per share, in the currency the company pays

Paid for 3 years. Last went ex-dividend on 5 Sept 2025.

FY2025FY2024FY2023FY2021FY2020FY2019FY2018
Paid in the year0.830.9990.500.6330.6750.5890.13
  • 21-for-20 split · 7 Sept 2023
  • 11-for-10 split · 11 Nov 2022

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.